{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:35Z","timestamp":1782722735235,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jss.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:46:50Z","timestamp":1780145210000},"page":"162-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adherence to Guidelines and Survival Impact of Radioactive Iodine in Oncocytic Thyroid Carcinoma: A National Cancer Database Study"],"prefix":"10.1016","volume":"324","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0142-4552","authenticated-orcid":false,"given":"Tony","family":"Boualoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra H.","family":"Helbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3434-9329","authenticated-orcid":false,"given":"Ambria S.","family":"Moten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2026.05.001_bib1","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1007\/s12325-021-01876-7","article-title":"H\u00fcrthle Cell Carcinoma of the thyroid gland: systematic review and meta-analysis","volume":"38","author":"Coca-Pelaz","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.jss.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1245\/s10434-023-13241-9","article-title":"Racial and ethnic disparities in appropriate thyroid cancer treatment, before and after the release of the 2015 American Thyroid Association Guidelines","volume":"30","author":"Ginzberg","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.05.001_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/thy.2021.0424","article-title":"Follicular and Hurthle Cell Carcinoma: comparison of clinicopathological features and clinical outcomes","volume":"32","author":"Matsuura","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.jss.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"6873","DOI":"10.2147\/OTT.S119980","article-title":"H\u00fcrthle cell carcinoma: current perspectives","volume":"9","author":"Ahmadi","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jss.2026.05.001_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12885-017-3370-x","article-title":"Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience","volume":"17","author":"Oluic","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jss.2026.05.001_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1677\/erc.1.01143","article-title":"Enhancement of sodium\/iodide symporter expression in thyroid and breast cancer","volume":"13","author":"Kogai","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jss.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/erc.1.01119","article-title":"The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+\/I- targeting to the membrane","volume":"13","author":"Riesco-Eizaguirre","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.jss.2026.05.001_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1530\/EC-17-0302","article-title":"NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features","volume":"7","author":"Tavares","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jss.2026.05.001_bib9","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/clinem\/dgac448","article-title":"Radioactive iodine therapy does not improve cancer-specific survival in H\u00fcrthle Cell Carcinoma of the thyroid","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN Clinical Practice Guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jss.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3389\/fendo.2023.1158581","article-title":"Radioactive iodine therapy strategies for distinct types of differentiated thyroid cancer: a propensity score\u2013matched analysis","volume":"14","author":"Guo","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jss.2026.05.001_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2026.05.001_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1089\/thy.2020.0237","article-title":"Changes in population-level and institutional-level prescribing habits of radioiodine therapy for papillary thyroid cancer","volume":"31","author":"Jacobs","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.jss.2026.05.001_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"2025 American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.jss.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/j.ejso.2019.06.025","article-title":"Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients","volume":"45","author":"Moten","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.suronc.2019.05.011","article-title":"The overuse of radioactive iodine in low-risk papillary thyroid cancer patients","volume":"29","author":"Moten","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jss.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jamcollsurg.2014.12.014","article-title":"Use of radioiodine after Thyroid lobectomy in patients with differentiated Thyroid cancer: does it change outcomes?","volume":"220","author":"Kiernan","year":"2015","journal-title":"J Am Coll Surgeons"},{"key":"10.1016\/j.jss.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"E962","DOI":"10.1210\/jc.2012-3539","article-title":"Genomic dissection of Hurthle Cell Carcinoma reveals a unique class of thyroid malignancy","volume":"98","author":"Ganly","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jss.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426002854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480426002854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:07:26Z","timestamp":1782720446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480426002854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S0022480426002854"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2026.05.001","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to Guidelines and Survival Impact of Radioactive Iodine in Oncocytic Thyroid Carcinoma: A National Cancer Database Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}